Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

biote Corp. Director's Dealing 2025

May 14, 2025

33946_dirs_2025-05-14_fae12030-6f91-463a-9cad-12e1cf1779d9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: biote Corp. (BTMD)
CIK: 0001819253
Period of Report: 2025-05-13

Reporting Person: Jacoby Dana Lynn (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-05-13 Class A Common Stock M 12994.00 Acquired 63964.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-05-13 Deferred Settlement RSU $ M 12994.00 Disposed Class A Common Stock (12994.00) Direct
2025-05-13 Deferred Settlement RSU $ A 21587.00 Acquired Class A Common Stock (21587.00) Direct
2025-05-13 Stock Option (Right to Buy) $3.91 A 104547.00 Acquired 2035-05-12 Class A Common Stock (104547.00) Direct

Footnotes

F1: Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock.

F2: The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2025 or the date of the Reporting Person's separation from service.

F3: The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the date of the Reporting Person's separation from service.

F4: All shares subject to the option award shall vest on the earlier of May 13, 2026 or the day prior to the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.